CagriSema Leads to Weight Reduction of Approximately 23% in Phase 3 REDEFINE 1 Clinical Trial, Short of the 25% Expected
The 22.7% weight loss at 68 weeks places CagriSema essentially on par with, not superior to, competing antiobesity drugs including Lilly's tirzepatide.
Atogepant Improves QoL in Chronic, Episodic Migraine: Daily Dose
Your daily dose of the clinical news you may have missed.
Women are at Higher Genetic Risk for PTSD than Men, According to Large Twin-Sibling Study
In the largest twin-sibling study to date of the inherited biological risk of PTSD, researchers found additive genetic and unique environmental effects contributed to the disorder.
Targeted Intervention Boosts Colorectal Cancer Screening Rates among Underserved US Adults
A centralized mailed FIT outreach intervention significantly improved CRC screening in a diverse patient population, according to recent data
Vertex Nonopioid Analgesic on Par with Placebo in Phase 2 Study of Lumbosacral Radiculopathy
Pain relief with suzetrigine was comparable to that seen with placebo, an issue Vertex plans to address with study design as the drug moves to the pivotal phase 3 trials.
Fremanezumab for Prevention of Episodic Migraine in Children: Daily Dose
Vaccination Information and Educational Resources from the National Foundation for Infectious Diseases
Robert Hopkins, Jr, MD, NFID medical director, details a range of resources on the foundation's website including in-depth vaccine recommendations, live webinars, plus much more.
CDC Adds Heplisav-B to Recommendations for HepB Vaccination During Pregnancy
The addition, based on an approved update to labeling, expands to 4 the recommended vaccination options that health care professionals can offer to pregnant people.
Sanofi Investigational COVID-19/Influenza Combination Vaccines Granted FDA Fast-Track Designation
The 2 novel vaccine candidates each combine a Sanofi licensed influenza vaccine with the Novavax adjuvanted recombinant COVID-19 vaccine.
Prenatal Exposure to Antibiotics May Increase Risk for Long-Term Health Problems in Children
The potential adverse outcomes include asthma, food allergies, cerebral palsy, and cancer, according to a recent systematic review and meta-analysis.
A Vaccination Imperative: "Please, Let's Do It," NFID Medical Director Robert Hopkins, Jr, MD, Urges
The National Foundation for Infectious Diseases medical director appeals to the community at large to set politics and personal grievance aside and to "first, do no harm."
US Adults Lagging in Flu, COVID-19, and RSV Vaccination: Daily Dose
Future of Obesity Care: 3 Wishes from Thought Leader Donna Ryan, MD
When asked about her 3 wishes for the future of obesity care, Donna Ryan, MD, told Patient Care that she had just one: access.
FDA Accepts NDA for TNX-102 SL, Tonix Nonopioid Analgesic for Fibromyalgia
If approved, the nonopioid, centrally acting analgesic would be the first in a new class of medications for fibromyalgia in more than 15 years, Tonix said.
Expert Perspectives 2024: Breakthrough Therapy for Congenital Adrenal Hyperplasia with PI Richard Auchus, MD, PhD
The lead investigator of the largest clinical trial program in people with CAH discusses the condition, its burden, and the novel drug just approved that will change lives.
FDA Accepts Merck's BLA for Clesrovimab, an Investigational mAb Against RSV in Infants
Clesrovimab, if approved, would be the only immunization for both healthy and at risk infants using the same dose. FDA set A PDUFA date of June 2025.
Investigational Maridebart Cafraglutide Shows Promise for Obesity, T2D: Daily Dose
FDA Receives sNDA for Roflumilast Cream 0.05% to Treat Atopic Dermatitis in Children Aged 2 to 5 Years
Arcutis Biotherapeutics announced submission of the sNDA today, citing the the supporting positive data from the phase 3 INTEGUMENT-PED and INTEGUMENT-OLE trials.
FDA Approves Nemolizumab for Treatment of Moderate-to-Severe Atopic Dermatitis
Nemolizumab is the first approved monoclonal antibody that targets IL-31 receptor alpha, inhibiting the signaling of IL-31, which drives disease mechanism in atopic dermatitis.
January Issue of Patient Care Online Digital Edition is Now Live
Find details on US colorectal cancer screening rates, dietary interventions for people with IBS, and research on the primary drivers of cost of IBD care.
